Multitarget Therapy for Idiopathic Membranous Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

February 3, 2021

Study Completion Date

February 3, 2022

Conditions
Efficacy
Interventions
DRUG

Prednisone, ciclosporin and mycophenolate mofetil

Multitarget Therapy

DRUG

Ponticelli Regimen

Month 1: i.v. methylprednisolone (0.5 g) daily for three doses, then oral prednison (0.5 mg/kg/d, maximum dose 30mg/d) for 27 days Month 2: Oral cyclophosphamide (2.0 mg/kg/d, maximum dose 100mg/d) for 30 days Month 3: Repeat Month 1 Month 4: Repeat Month 2 Month 5: Repeat Month 1 Month 6: Repeat Month 2

Trial Locations (2)

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Frienship Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Friendship Hospital

OTHER

NCT04424862 - Multitarget Therapy for Idiopathic Membranous Nephropathy | Biotech Hunter | Biotech Hunter